Mesenchymal stem cell therapy for liver fibrosis
Currently, the most effective treatment for end-stage liver fibrosis is liver transplantation; however, transplantation is limited by a shortage of donor organs, surgical complications, immunological rejection, and high medical costs. Recently, mesenchymal stem cell (MSC) therapy has been suggested...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Association of Internal Medicine
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578027/ |